Skip to Content

Metacrine Inc.

Merger

  • Date:
  • 9/6/2022
  • Company Name:
  • Metacrine Inc.
  • Stock Symbol:
  • MTCR
  • Company Name - Buyer:
  • Equillium, Inc.
  • Stock Symbol - Buyer:
  • EQ
  • Status:
  • Investigating
  • Merger Announcement Date:
  • 9/6/2022

Case Finder

Locate any case using the tools below.

NEW YORK, September 6, 2022 – Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of Metacrine Inc. (NASDAQ: MTCR) (“Metacrine”) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by Equillium, Inc. (NASDAQ: EQ) (“Equillium”).

On September 6, 2022, Metacrine announced that it had entered into an agreement to be acquired by Equillium in an all-stock deal with an enterprise value of $26 million. Pursuant to the merger agreement, Equillium will issue stock valued at a 25% premium over the net cash delivered at closing, which is estimated to be approximately $26 million. Net cash is total cash, cash equivalents, and short-term investments, adjusted by certain factors including debt, which includes term debt with an outstanding principal of $15 million, and other liabilities, as defined in the merger agreement. The deal is expected to close in late 2022.

Bragar Eagel & Squire is concerned that Metacrine’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Metacrine’s stockholders.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Metacrine Inc.. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: